Pfizer CEO Albert Bourla visited at a press conference on April 23, 2021 at the Pfizer factory in the US pharmaceutical company Pfizer in Puurs, Belgium, to oversee the production of the Pfizer-BioNTech COVID-19 vaccine. I will give a speech.
John Thys | Pool | Reuters
Pfizer We look forward to publishing clinical trial data on how well it works. COVID-19 The vaccine will work for children aged 6 months to 5 years by the end of October at the earliest, CEO Albert Bourla said Tuesday.
Corona vaccine data for children aged 5 to 11 arrived earlier and may be ready to be submitted to the Food and Drug Administration by the end of this month, he said.
“Then it’s up to the FDA to take the time to make decisions,” Bourla said in Research! Said in an interview with America’s 2021 National Health Research Forum.
The CEO’s comment states that many parents are anxious to vaccinate their children, especially as schools reopen and highly contagious delta variants continue to spread. This tension has led to a surge in hospitalizations across the United States. Among young children Those who are not currently eligible to take shots.
On Friday, FDA officials said they saidI work 24 hours a day“To support the approval of the Covid vaccine for children under the age of 12.
Dr. Peter Marks, FDA’s top vaccine regulator, said last month that once the company submitted the data, the authorities would move as “quickly” as possible to approve shots for children under the age of 12.
“Currently, trials are still underway, so the agency must wait for the company to submit data for those trials,” he said on August 23.
Pfizer’s Covid vaccine data for children under the age of 5 may be released in late October, CEO said
Source link Pfizer’s Covid vaccine data for children under the age of 5 may be released in late October, CEO said